GENE ONLINE|News &
Opinion
Blog

2022-01-10| Asia-PacificIPO

Vertex Is Looking to Become Singapore’s First SPAC

by Joy Lin
Share To

Last September, the Singapore Exchange (SGX) changed its framework to allow special purpose acquisition companies (SPACs) to list. Now, Vertex Technology Acquisition Company (VTAC) is set to become the first SPAC to list in the country, after the company lodged a preliminary prospectus with the Monetary Authority of Singapore (MAS).

A subsidiary of Singapore venture capital firm Vertex Holdings, VTAC is seeking to raise S$200 million (nearly $150 million), by selling 40 million units at an offered price of S$5.00 each.  

VTAC announced that 13 cornerstone investors, including UBS Asset Management, Venezio Investments, and Fullerton Fund Management Company, have subscribed to 65% of the shares offered, accounting for 22.2 million units that will raise S$111 million. 

Its sponsor Vertex Venture Holdings have also booked $30 million for the fundraising through its subsidiary Vertex Co-Investment Fund. 

When it lists at the end of the month, VTAC will have 24 months to complete a reverse merger. While VTAC did not disclose any specific combination targets in its prospectus, its focus will be on biotech and digital healthcare, and technologies related to artificial intelligence, cyber security and enterprise, consumer Internet, finance, autonomous driving, and new energy vehicles.

SPACs in Asia 

 

SPAC listings may become more common in Asia as countries change their frameworks. Hong Kong recently changed its rules to allow SPACs to begin listing this January. Elsewhere, SPACs have already been greenlighted in Korea and Malaysia, and are given 36 months to complete an acquisition compared to the usual 24.

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
AbbVie Boosts Global Manufacturing with $223 Million Expansion in Singapore
2024-01-29
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
LATEST
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top